The symptomatic, electrocardiographic, and circulatory effects of intravenous and oral preparations of propranolol, oxprenolol, and practolol were compared in 16 patients with uncomplicated angina pectoris precipitated by exertion. The method of study included treadmill exercise, double-blind assessment, single-blind analysis, with placebo control and randomized serial comparison of each drug in each patient. The doses used were selected to give the same near-maximum suppression of the heart rate response to exercise. The symptomatic, electrocardiographic, and circulatory response of each patient to both preparations of each of the three drugs was similar. Exercise tolerance was increased in two-thirds, unchanged in one-sixth, and significantly worsened in onesixth of the studies. Electrocardiographic evidence of myocardial ischaemia was conspicuously reduced by all three drugs in most studies irrespective of their symptomatic effects. Though the exclusive choice of patients, the single dose design of the trial, and the treadmill method of assessment limit the general application of these results, they do clearly indicate that in doses that induce equal suppression of the exercise heart rate these three drugs have similar distinct anti-anginal activity. Their ancillary pharmacological properties are probably of little importance in this respect. Equally, the similarity in the symptomatic, circulatory, and electrocardiographic response to the intravenous and oral preparations suggests that metabolic breakdown products are probably of therapeutic importance only in so far as they antagonize beta-receptor activity.
Introduction
The beneficial symptomatic effects of the adrenergic betareceptor antagonists in angina pectoris are well known, but there is little information on the comparative effectiveness of different preparations. This is of particular clinical interest, as the most common drugs used-propranolol, oxprenolol, and practolol-differ conspicuously in their secondary pharmacological properties. In addition, the ingestion of these drugs is followed by the formation of metabolic degradation products with potentially different anti-anginal activities to those of the unchanged intravenous preparation. In view of the possible clinical importance of these differences the following study was undertaken to evaluate the comparative therapeutic effectiveness of the intravenous and oral preparations of the three drugs in patients with angina pectoris. 
Patients %nd Methods
The design of the trial involved the serial evaluation in each patient of the effect of placebo, propranolol, oxprenolol, and practolol, and to achieve a balanced analysis 16 men, average age 52 years (range 38-60) and average weight 75 kg (range 67-82), were studied. All were suffering from uncomplicated exercise-induced angina pectoris. None were obese, hypertensive, or diabetic, none had hypercholesterolaemia and none had had a previous myocardial infarction or any other history of heart disease. The history of angina extended from four months to eight years (average 23 months) and in all patients was induced solely and repeatably by walking. In all cases the angina was judged to be stable by the historical evidence of relative constancy of the number of attacks and daily glyceryl trinitrate consumption, the repeatable time of onset during objective exercise testing, and the rapid relief afforded by subsequent rest. None suffered from nocturnal or emotionally-induced angina, and none had received previous treatment other than glyceryl trinitrate.
The resting electrocardiogram was normal in all patients, but during treadmill exercise all developed ischaemic changes at the onset of pain. The diagnostic criteria of ischaemic electrocardiographic response used was a flat or downward sloping depression of the S-T segment in chest lead V5 of at least 1 mm (0 1 mV) persisting for 0 08 seconds or longer and present in five successive beats with a stable isoelectric baseline. A positive response is illustrated in fig. 1 . A standardsix-foot(1-8m) standing chest radiograph showed no cardiac enlargement, and radiographic screening showed no abnormality of left ventricular contraction. There was no auscultatory or angiographic evidence of mitral incompetence in any patient and all had angiographic evidence of multiple coronary artery disease. Objective evidence of the presence of exercise-induced left ventricular myocardial ischaemia was also furnished by the fact that in all patients the left ventricular end-diastolic pressure was less than 12 mm Hg at rest, rose abruptly to more than 25 mm Hg during angina, and returned rapidly and completely to normal in parallel with the resolution of the electrocardiographic S-T segment depression, as previously described (Sharma and Taylor, 1970) .
The patients selected for this trial formed part of a medical cont:ol population of a randomized trial for the evaluation of the results of coronary artery bypass surgery. The purpose and nature of the investigative programme, the possible clinical benefits, and the scientific aspects of the study were explained in detail to each patient; without inducement all consented willingly to the studies (Medical Research Council Annual Report, 1964; Ormrod, 1968 Studies were carried out every third day and begun five minutes after the intravenous infusion of normal saline, propranolol (0-2 mg/kg), oxprenolol (0-2 mg/kg), or practolol (2-0 mg/kg) administered in random order by a motor driven pump in a dilution of 80 ml over five minutes. The oral studies were then carried out every third day starting one hour after oral placebo (10 mg ascorbic acid), propranolol (80 mg), oxprenolol (80 mg), or practolol (500 mg), again administered in random order.
The intravenous and oral doses of the three beta-adrenoreceptor antagonists were chosen after pilot studies in normal volunteers had shown that these doses resulted in a comparable degree of blockade of the heart rate response to intravenous isoprenaline and a near-maximum reduction in the heart rate response to supine leg exercise .
The order of administration of placebo and the three drugs was decided by a series of random numbers. The content of the injection or the tablets was not known to the patient or doctor in charge of the investigation. The electrocardiogram and heart rate were monitored continuously on an oscilloscope and cardiotachometer respectively throughout each study. Electrocardiographic records were taken and sphygmomanometric measurements of the brachial arterial pressure were made at each minute throughout the study. The patients' indication of the onset of pain was separately documented. The electrocardiograph records were analysed by a third observer who was not present at the time of the study and who had no knowledge of the drug given or the time of onset of pain. The study was therefore a serial comparison, double-blind in design and single-blind in analysis, placebo controlled, randomized in order, with each patient serving as his own control.
rECHNIQUES, MEASUREMENTS, AND STATISTICAL METHODS
The electrocardiogram was recorded from adhesive-disc electrodes applied to each shoulder, lower rib-cage, and the V5 position, calibrated extemally (1 mm = 0 1 mV), and recorded on an ultraviolet recorder (SE Laboratories model 3012) at a 139 recording speed of 50 mm/sec. S-T segment depression was measured as the linear depression of the J point from the isoelectric line joining two consecutive P-R segments. The J point was indentified as the first detectable point of change after the nadir of the S wave ( fig. 1 ). This point is least affected by the random artefacts that occur on the exercise electrocardiogram and it is also probably clear of changes due to atrial repolarization. T wave height was measured as the peak height from the isoelectric line. Measurements were averaged over five consecutive complexes in which the isoelectric line was completely stable. Heart rate was measured from the same electrocardiogram complexes. The systemic arterial pressure was measured by sphygmomanometer from the right brachial artery.
Measurements were made at one-minute intervals and averaged during the final two minutes of each six-minute phase of the study. There was a significant reduction in the resting standing heart rate in all patients after each of the three drugs by both routes of administration (tables II and III). The higher resting heart rates after intravenous oxprenolol (P < 0 05) and practolol (P < 0 02) as compared to propranolol may reflect the intrinsic sympathomimetic activity of these two drugs when administered in this form. The higher resting heart rate after oral practolol (P < 0 001) as compared to oral oxprenolol and propranolol possibly indicates a similar phenomenon. The higher resting heart rate after intravenous as compared to oral oxprenolol (P < 0 05) may indicate that its sympathomimetic activity is reduced when given orally.
The equal reduction in exercise tachycardia after each drug by both routes of administration implied a similar degree of blockade of the cardiac heart rate beta-receptors to the sympathetic effects of exercise.
COMPARISON OF INTRAVENOUS PREPARATIONS
Symptoms.-All patients experienced angina during the placebo study ( fig. 2 ). Each of the three drugs produced a statistically nificant increase in the peak height of the T waves at without change in the isoelectric S-T segment. During exercise in the placebo study there was conspicuous depression of the S-T segment in all patients (P < 0 001). This was significantly diminished in 15 of the 16 patients after all three beta-receptor antagonists, irrespective of the effect on symptoms. The peak height of the T wave during exercise was unchanged after all three drugs.
Changes in Heart Rate and Blood Pressure.-There was a significant reduction in the heart rate both at rest and during treadmill exercise after each drug as compared to placebo (table II, figs. 3 and 4) . The systemic arterial pressure of all patients was within the normal range at rest (a criteria of patient selection). There was no conspicuous change in the resting blood pressure, but during exercise there was a significant reduction in the average systolic pressure after all three drugs; the diastolic pressure was unchanged. fig. 2 ). Each of the three drugs produced a statistically significant increase in the peak height of the T wave at rest without change in the isoelectric S-T segment. During exercise in the placebo study there was conspicuous depression of the S-T segment (P < 01001). This was significantly diminished in 13 of the 14 patients after all three beta-receptor antagonists, irrespective of the effect on symptoms. The peak height of the T wave during exercise was unchanged after all three drugs.
Changes in Heart Rate and Blood Pressure.-There was a conspicuous reduction in heart rate both at rest and during treadmill exercise after each drug as compared to placebo (table  III, figs. 3 and 4) . The systemic blood pressure of all patients was within the normal range at rest. The systolic blood pressure before, during, and after treadmill exercise was significantly reduced by all three drugs; the diastolic pressure was unchanged.
COMPARISON OF CHANGES AFTER INTRAVENOUS AND ORAL PREPARATIONS
There was a relatively close level of agreement between the changes in symptoms, changes in electrocardiogram, and changes in heart rate and blood pressure after the two modes of administration of all three drugs. Of the eight patients who improved after intravenous propranolol, seven improved after the oral preparation. Similar figures for oxprenolol were eight and six, and for practolol nine and six. Changes in the degree of electrocardiographic S-T depression and peak height of the T wave, changes in heart rate, and changes in systolic blood pressure were not statistically significantly different after the intravenous and oral administration of any of the three drugs, except that the heart rate was higher after intravenous as compared to oral oxprenolol.
CORRELATION BETWEEN CHANGES IN EXERCISE TOLERANCE, ELECTROCARDIOGRAM, HEART RATE, AND SYSTEMIC ARTERIAL

PRESSURE
There was no meaningful correlation between the changes in exercise tolerance and changes in S-T segment depression. All but one patient showed conspicuous reduction in electrocardiographic S-T segment depression after all three drugs by both routes of administration. Thus there was a reduction in S-T depression in 84 of 90 studies, irrespective of changes in time of onset of pain. There was a reduction in the degree of S-T segment depression in patients in whom there was no change in symptoms or even in those in whom angina was worsened. Conversely, pain was relieved in the patient who showed no electrocardiographic improvement.
There was a close relation between the degree of S-T segment depression and heart rate (r = 0-380; P < 01001) and between S-T segment depression and systolic blood pressure (r =0'256; P < 0-01) when all studies were grouped together. In both instances values were normally distributed along the calculated regression line.
Discussion
This study was particularly concerned with testing the comparative effectiveness of single intravenous and oral doses of propranolol, oxprenolol, and practolol in patients with exerciseinduced angina pectoris for the reasons outlined in the introduction. The results are clear-cut but to bring them into therapeutic perspective it is essential to emphasize the specific factors in the trial that may limit their more general clinical application.
Patients against an agonist such as isoprenaline, or the less precise method of equating the dose of each drug in terms of the degree of heart rate suppression to a constant exercise load. Both methods were used in the present study. The doses of drugs used were equated in terms of their dose-response relation to isoprenaline-induced tachycardia; the final single doses used were chosen on the basis that they produced a near-axmimum suppression of the heart rate during teadmill exercise (Taylor et al., 1973) .
These critical reservations naturally detract from the wider application of these findings to the general angina population in everyday life on long-term treatment with beta-receptor antagonists. But their specific validity is enhanced by a number of the design aspects of the trial. Rigid precautions were taken to eliminate patient and observer bias, reproducibility of symptoms was carefully defined in each patient, the method of assessment was carefully chosen to impart sufficient sensitivity to the test situation to allow adequate discrimination between individual changes in exercise tolerance, the study was placebocontrolled, double-blind in design with single-blind analysis, and the drugs under comparison were administered in random serial order to each patient.
The results clearly showed that two-thirds of expected anginal attacks were abolished or significantly shortened by all of the beta-receptor antagonists, and in the doses used each drug was equally efficacious in this respect. Despite some individual patient variation most patients who responded to one preparation also responded to the others. Electrocardiographic evidence of left ventricular myocardial ischaemia was conspicuously reduced irrespective of the changes in anginal pain; all three drugs were equally effective in this respect. Likewise, the reduction in exercise tachycardia and systolic blcod pressure was universal after all three drugs in both modes of administration, again irrespective of changes in exercise tolerance.
There was no meaningful relation between the changes in exercise tolerance or any of the objective circulatory or electrocardiographic variables measured. But there was a significant correlation between the circulatory and electrocardiographic changes both in the individual patient and in the grouped results.
These findings may be interpreted as indicating that in equal heart rate suppressive doses all three drugs are similarly effective in lessening the degree of myocardial ischaemia and improving exercise tolerance in most patients with exerciseinduced angina pectoris. But it must also be emphasized that despite similar reductions in heart rate and blood pressure during exercise and equal improvement in electrocardiographic evidence of myocardial ischaemia, 15 % of anginal attacks were worsened by these drugs. Despite the debate that has recently centred around the possible pathophysiological mechanisms involved (Robinson, 1971; Taylor, 1973) this therapeutic paradox remains one of the outstanding problems in the management of angina pectoris with these agents.
Although there are many reports of the effects of betareceptor antagonists in angina pectoris, most fail to satisfy the criteria necessary to interpret their findings in the general clinical scene (Sharma and Taylor, 1973) . In many studies the patients have been poorly defined or their selection has been such as to comprise a clinically heterogenous group. The design of the trial has rarely been adequate. The method of assessment has often depended on historical subjective criteria alone, and the sensitivity of discrimination of the changes under study has been frequently insufficient to support the quantitative conclusions reached. These criticisms apply with added emphasis to most comparative therapeutic trials reported, in which equipotency of drug dosage has also been largely ignored. But in those trials which satisfy many of the essential criteria of patient selection, trial design, and method of assessment comparison of two or more of these drugs either in intravenous or oral form has yielded similar results to the present study (Wilson et al., 1969; Prichard et al., 1970; Sharma et al., 1971; Coltart, 1971) . However, we know of no serial single-dose comparative evaluation of the symptomatic electrocardiographic and circulatory effects of these three drugs in equivalent dosage in intravenous and oral form, other than that of the present study.
In addition to the direct therapeutic results and conclusions, there are a number of additional observations that are of wider interest. Much discussion has centred around the possible therapeutic value of the various ancillary pharmacological properties of the beta-receptor antagonists. These properties include local anaesthetic or membrane stabilizing activitypossessed by propranolol and oxprenolol but not by practolol; intrinsic sympathomimetic activity-possessed by oxprenolol and practolol but not by propranolol; cardioselective activitypossessed by practolol but not by propranolol or oxprenolol; and ability to penetrate the blood-brain barrier and cause "central" effects-possessed by propranolol but not by practolol. The fact that in equipotent doses, at least as judged by the suppression of the heart rate response to exercise, these three drugs were equally efficient in improving exercise tolerance would suggest that these ancillary pharmacological properties are of little or no direct relevance in the relief of anginal pain. In addition, although these studies cannot supply a direct answer as to the specific importance of the unchanged drug or its metabolic breakdown products in the relief of angina, the fact that similar symptomatic, electrocardiographic, and circulatory effects results after their intravenous and oral administration in all instances affords some evidence that such breakdown products are probably of therapeutic relevance only in so far as they exert antagonism against endogenous sympathetic activity at the cardiac beta-receptor sites.
Finally, it is important to emphasize that these studies furnish no information of the dose-response relation to any of the three drugs and neither do they allow the identification of patients in whom symptoms may be improved or aggravated. But if it is accepted that the electrocardiographic changes do indeed represent lessening of myocardial ischaemia, and there is reasonable evidence for such an assumption (Kemp et al., 1968; Braunwald et al., 1969; Reid et al., 1971) , then the fact that these agents result in conspicuous electrocardiographic improvement in nearly all patients irrespective of their effect on symptoms suggests that these drugs may possibly afford some long-term benefit despite their less than ideal symptomatic performance in many anginal patients.
